Free Trial

Genetic Technologies (GENE) SEC Filings & 10K Form

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)
Free GENE Stock Alerts
$1.98
+0.04 (+2.06%)
(As of 05/31/2024 ET)
Compare
Stock AnalysisChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends

Recent Genetic Technologies SEC Filings

Export to Excel
DateFilerForm TypeView
05/29/2024
5:05 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/27/2024
11:15 PM		Genetic Technologies (Filer)
Form EFFECT
05/06/2024
5:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/30/2024
5:02 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
5:45 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
5:35 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
5:40 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/23/2024
5:30 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
8:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
5:05 AM		Genetic Technologies (Filer)
Form 424B5
04/19/2024
5:10 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/17/2024
5:05 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/22/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/15/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
1:14 PM		CVI Investments, Inc. (Filed by)
Genetic Technologies (Subject)
Form SC 13G/A
02/07/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/31/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/05/2024
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2024
11:15 PM		Genetic Technologies (Filer)
Form EFFECT
12/28/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/20/2023
4:00 PM		Genetic Technologies (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
12/19/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2023
1:37 PM		Genetic Technologies (Filer)
Form 424B3
12/07/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/06/2023
5:15 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/04/2023
2:31 PM		Genetic Technologies (Filer)
Form 424B3
12/01/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/30/2023
9:21 AM		Genetic Technologies (Filer)
Form 424B3
11/24/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2023
6:45 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
11/21/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/30/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2023
7:30 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/31/2023
7:10 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2023
7:15 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/30/2023
7:00 AM		Genetic Technologies (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
07/28/2023
7:00 AM		Genetic Technologies (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:GENE) was last updated on 6/2/2024 by MarketBeat.com Staff

From Our Partners
Biden Nomination CANCELED?
The Freeport Society
Trump’s Gift Could Unleash $51 Billion in New Wealth
Wealthpin Pro
Biden replacement revealed?
Paradigm Press
Buy this small stock before coming AI Tidal Wave
Chaikin Analytics
Warren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…
InvestorPlace
Nvidia has Apple and Microsoft within striking range
Weiss Ratings
Don’t buy a single NVIDIA share before you see this...
Behind the Markets
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders